Newsfeed

Progranulin-Boosting Drug Moves into Phase 2 for Frontotemporal Dementia

A drug being tested for cases of FTD with a progranulin mutation moves into phase 2. Read the article here.

Amid loss, Minn. author Nancy Carlson still makes children’s books

Author Nancy Carlson describes her journey caring for her husband, who has FTD. Read the article here.

A Symphony for Douglas

An article, posted on CantonRep.com, about a symphony written by Linda Anne Bentz Parsons and orchestrated, arranged and directed by Steve Parsons in honor of Douglas Parsons, who has FTD. Click here for the full article.

RARE BRAIN DISEASE RESEARCHERS TO RECEIVE MORE THAN $30 MILLION IN FUNDING OVER NEXT 5 YEARS

Researchers studying frontotemporal degeneration (FTD) disease, a leading cause of early onset dementia, will receive more than $30 million over the next five years in grants from the National Institutes of Health (NIH). The funding will be used to further scientific collaboration and investigate new treatments in the quest to find a cure for FTD. Click here to read full release.

Porter Road Butcher Fights FTD

AFTD’s friends at Porter Road Butcher hosted a Food for Thought event for the second year, donating 10% of the day’s profits and setting up tents outside to educate shoppers about FTD. Read the article here.